Millrace Asset Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-65,735
Closed -$1.09M 62
2022
Q3
$1.09M Sell
65,735
-27,236
-29% -$613K 1.38% 32
2022
Q2
$1.85M Buy
+92,971
New +$1.88M 1.73% 26
2021
Q1
Sell
-4,323
Closed -$212K 90
2020
Q4
$212K Sell
4,323
-6,848
-61% -$317K 0.15% 75
2020
Q3
$363K Sell
11,171
-15,684
-58% -$499K 0.29% 75
2020
Q2
$696K Sell
26,855
-21,169
-44% -$527K 0.71% 63
2020
Q1
$1.17M Sell
48,024
-5,516
-10% -$139K 1.76% 22
2019
Q4
$1.5M Sell
53,540
-31,460
-37% -$814K 1.63% 28
2019
Q3
$2.04M Buy
85,000
+12,000
+16% +$319K 2.39% 6
2019
Q2
$2.08M Sell
73,000
-60,000
-45% -$1.5M 2.15% 8
2019
Q1
$3.33M Sell
133,000
-77,000
-37% -$1.47M 2.81% 2
2018
Q4
$2.64M Sell
210,000
-70,000
-25% -$828K 2.42% 7
2018
Q3
$2.67M Buy
280,000
+50,000
+22% +$551K 2.08% 12
2018
Q2
$2.15M Buy
+230,000
New +$1.62M 1.64% 27

Other funds holding VCYT

Millrace Asset Group's VCYT Position: Q4 2022 in Review

Millrace Asset Group sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 65,735 shares — an estimated $1.09M sold.

Millrace Asset Group first reported a position in VCYT in Q2 2018 and held it in 13 quarters. The position peaked at $3.33M in Q1 2019. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

  • Millrace Asset Group reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
  • Millrace Asset Group sold 65,735 Veracyte shares in Q4 2022, an estimated $1.09M.
  • Millrace Asset Group first reported a position in Veracyte in Q2 2018 and held it in 13 quarters.
  • Millrace Asset Group's Veracyte position peaked at $3.33M in Q1 2019.
  • 223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Millrace Asset Group's 13F filing for Q4 2022, filed 13 Feb 2023.